Role of pharmacogenomics for prevention of hypersensitivity reactions induced by aromatic antiseizure medications

Epilepsy is the second most common neurological condition worldwide, characterized by recurrent, unprovoked, self-limiting seizures of genetic, acquired, or unknown origin. The objective was to describe the pharmacogenomic markers associated with hypersensitivity reactions induced by aromatic antise...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Angel T. Alvarado, Amparo Iris Zavaleta, César Li-Amenero, María R. Bendezú, Jorge A. Garcia, Haydee Chávez, Juan J. Palomino-Jhong, Felipe Surco-Laos, Doris Laos-Anchante, Elizabeth J. Melgar-Merino, Pompeyo A. Cuba-Garcia, Paulina E. Yarasca-Carlos
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-08-01
coleção:	Frontiers in Pharmacology
Assuntos:	pharmacogenomics hypersensitivity reactions antiseizure medications epilepsy clinical implications
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1640401/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!